In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Robotic Stereo-Electroencephalography in Medically Refractory Focal Epilepsy

    Final Number:
    771

    Authors:
    Soha Abdu Alomar MD, FRCSC, MPH; Jeffrey Mullin MD MBA; William E. Bingaman MD; Jorge Alvaro Gonzalez-Martinez MD, PhD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: Despite its long reported successful record, with almost 60 years of clinical use, the technical complexity regarding the placement of stereo-electroencephalography (SEEG) depth electrodes might have contributed to the limited widespread application of the technique and methodology in centers outside Europe.

    Methods: Analyses included all patients with medically refractory focal epilepsy who underwent robotic stereotactic placement of depth electrodes for extra-operative brain monitoring using the SEEG method between November 2009 and May 2013. All the procedures were performed using the robotic assistant device ROSAÒ. (Medtech, Montpellier, France). Technical nuances regarding the robotic implantation technique are presented as well as analysis of demographics, time of planning and procedure, application accuracy, seizure outcome, in vitro and in vivo accuracy and procedure-related complications.

    Results: One hundred patients underwent 250 robotic-assisted SEEG procedures. The mean age was 33.2 years. In total, 1245 depth electrodes were implanted. On average, 12.5 electrodes were implanted per patient. All procedures were completed without cancellations due to hardware or software dysfunction. Time of planning was 30 minutes in average (ranging from 15 to 60 minutes). The average operative time was 130 minutes (range from 45 to 160 minutes). In vivo application accuracy, tested in 500 consecutive trajectories, demonstrated the mean entry point error of 1.3 ± 0.8mm (SD) and the mean target point error of 2.3 ± 0.9mm (SD). From the group of patients who underwent resective surgery (68 patients), 45 (66.2%) gained seizure freedom status. Mean follow-up was 18 months. Major complication rate was 1%.

    Conclusions: The robotic SEEG technique and method demonstrated to be safe, accurate and efficient in anatomically defining the epileptogenic zone and promoting seizure freedom status in patients with difficult to localize seizures. The findings from this study demonstrate its feasibility, translating into a modern and simplified alternative to the traditional SEEG technique, without compromising efficiency and safety

    Patient Care: this study demonstrates an efficient and safe technique for localization of epileptogenic zone with minimal complication.

    Learning Objectives: To report the clinical experience with robotic SEEG implantation, defining its utility in the management of patients with medically refractory epilepsy who are candidates for extra-operative invasive monitoring using the SEEG methodology.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy